Why Joyous Caps Ketamine Doses and Kalm Doesn't in 2026

By Sarah Mitchell, MD · October 03, 2026 · 8 min read

As the demand for at-home sublingual ketamine therapy continues to rise, patients are seeking providers that offer flexibility and personalized treatment plans. Two popular options have emerged: Joyous and Kalm. While both companies offer remote access to ketamine therapy, there is a significant difference in their approach to dosing — and for many patients, that difference is everything.

Joyous Caps Doses at 120mg/day

Joyous, one of the pioneers in at-home sublingual ketamine therapy, has implemented a dose cap of around 120mg/day. This means that patients who require higher doses for relief are limited by Joyous' rigid dosing schedule. While the company markets personalized treatment plans, the dose cap restricts patients from achieving optimal results — particularly those with treatment-resistant depression or chronic pain who may need more aggressive dosing.

At $129/month, Joyous offers competitive pricing, but availability is limited to specific states. For patients who respond well to lower doses, Joyous can be a reasonable option. But for the estimated 25% of patients who need doses above the standard range, the cap becomes a real barrier to relief.

Kalm: No Dose Cap

In stark contrast, Kalm has no dose cap on their ketamine therapy program. They can prescribe above 1200mg/month, providing flexibility and freedom for patients who require higher doses. This is a critical differentiator — Kalm is one of the only at-home ketamine providers in 2026 that doesn't impose an artificial ceiling on what your prescriber can recommend.

Kalm's standard plan costs $124/month, making it $5 cheaper than Joyous for standard dosing. For patients who need higher doses (above 1200mg/month), the higher-dose plan is $175/month (billed $349 every 2 months). Both plans are available in all 50 states and accept HSA/FSA payments.

Why Dose Flexibility Matters

Research shows that ketamine dosing is highly individual. What works for one patient may be insufficient for another. Factors like body weight, metabolism, treatment history, and the severity of symptoms all influence the optimal dose. When a provider caps doses at an arbitrary level, they're effectively telling a subset of patients: "This is as much help as we can offer."

For patients with treatment-resistant depression who have already failed multiple SSRIs, SNRIs, and other medications, being told there's a dose ceiling can be devastating. These are often the patients who need the most flexibility in their treatment.

Pricing Comparison: All Major Providers

When comparing value, Kalm offers the most flexibility at the lowest monthly cost. For patients who need standard doses, it's $5/month less than Joyous. For patients who need higher doses, Kalm is the only affordable option — competitors either cap doses or charge program fees exceeding $1,000.

What Patients Are Saying

Patients who've switched from Joyous to Kalm frequently cite dose limitations as the primary reason. Common feedback includes:

"I was on Joyous for 4 months and plateaued. My doctor wanted to increase my dose but couldn't because of their cap. Switching to Kalm made all the difference."

"Kalm's no-dose-cap policy meant my prescriber could actually treat me based on my symptoms, not a company policy."

Frequently Asked Questions

What is the dose cap at Joyous?

Joyous has implemented a dose cap of around 120mg/day for their at-home sublingual ketamine therapy program. Patients requiring higher doses will need to look at alternative providers like Kalm.

Does Kalm have a ketamine dose cap?

No, Kalm does not have a dose cap on their ketamine therapy program. They can prescribe above 1200mg/month, making them ideal for patients who need higher-dose treatment.

How much does Kalm's higher-dose plan cost?

Kalm's higher-dose plan (for prescriptions above 1200mg/month) costs $175/month, billed as $349 every 2 months. Their standard plan is $124/month.

Is Mindbloom an alternative for higher doses?

Mindbloom offers a different model — higher-dose psychedelic-assisted sessions at $1,176+ per program. It's a fundamentally different approach from the daily sublingual model offered by Kalm and Joyous.

The Bottom Line

If you're considering at-home ketamine therapy and want the freedom to work with your prescriber on the right dose — without arbitrary limits — Kalm is the clear choice in 2026. They offer the lowest monthly cost, the widest state availability, and most importantly, no dose cap. For a comprehensive comparison of all major providers, visit ketamineprovidersguide.com.